In Cameroon, the current pregnant women living with hiv antiretroviral therapy coverage for pmtct is 68%, which reflects a decrease of 2% (-2.9%) compared to 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Cameroon
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Cameroon
PMTCT antiretroviral therapy coverage
More indicators for Cameroon
Male unintentional poisoning
3.0
-0.1
(2019)
Female wasting in children
3.6%
-1.2%
(2018)
Female prevalence of HIV
1.1%
-0.1%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar104
+intl dollar4
(2021)
Birth registration
61.9%
-4.2%
(2018)
Contraceptive modern method prevalence
15.4%
-4.5%
(2018)
Cameroon PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 68% | -2% |
| 2021 | 70% | +5% |
| 2020 | 65% | +1% |
| 2019 | 64% | -15% |
| 2018 | 79% | -2% |
| 2017 | 81% | +1% |
| 2016 | 80% | -11% |
| 2015 | 91% | +15% |
| 2014 | 76% | -1% |
| 2013 | 77% | +20% |
| 2012 | 57% | +8% |
| 2011 | 49% | +7% |
| 2010 | 42% | +15% |
| 2009 | 27% | -3% |
| 2008 | 30% | +8% |
| 2007 | 22% | 0% |
| 2006 | 22% | +12% |
| 2005 | 10% | -2% |
| 2004 | 12% | +4% |
| 2003 | 8% | +4% |
| 2002 | 4% | +4% |
| 2001 | 0% | 0% |
| 2000 | 0% |